These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30498201)

  • 1. Tipping the balance: inhibitory checkpoints in intestinal homeostasis.
    Joosse ME; Nederlof I; Walker LSK; Samsom JN
    Mucosal Immunol; 2019 Jan; 12(1):21-35. PubMed ID: 30498201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria.
    Barnes MJ; Griseri T; Johnson AM; Young W; Powrie F; Izcue A
    Mucosal Immunol; 2013 Mar; 6(2):324-34. PubMed ID: 22910217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New checkpoints in cancer immunotherapy.
    Ni L; Dong C
    Immunol Rev; 2017 Mar; 276(1):52-65. PubMed ID: 28258699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing regulatory T cells for the treatment of inflammatory bowel disease.
    Geem D; Harusato A; Flannigan K; Denning TL
    Inflamm Bowel Dis; 2015 Jun; 21(6):1409-18. PubMed ID: 25793328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance.
    Shen X; Du J; Guan W; Zhao Y
    Expert Rev Clin Immunol; 2014 Mar; 10(3):353-62. PubMed ID: 24483245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
    Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
    J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
    Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
    Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
    Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
    Front Immunol; 2021; 12():637630. PubMed ID: 33717186
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
    Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
    Panda AK; Kim YH; Shevach EM
    J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.
    Pinchuk IV; Beswick EJ; Saada JI; Boya G; Schmitt D; Raju GS; Brenmoehl J; Rogler G; Reyes VE; Powell DW
    Gastroenterology; 2011 Jun; 140(7):2019-30. PubMed ID: 21376048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine.
    Doi T; Kanai T; Mikami Y; Sujino T; Jun L; Ono Y; Hayashi A; Hibi T
    Biochem Biophys Res Commun; 2012 Sep; 425(4):918-23. PubMed ID: 22906740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
    Holt MP; Punkosdy GA; Glass DD; Shevach EM
    J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma.
    Maeda S; Ohno K; Fujiwara-Igarashi A; Uchida K; Tsujimoto H
    Vet Pathol; 2016 Jan; 53(1):102-12. PubMed ID: 26173451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.
    Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Frydecka I; Pawlak E; Szmyrka M; Kosmaczewska A
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    Lord JD; Shows DM; Chen J; Thirlby RC
    PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
    Asano T; Meguri Y; Yoshioka T; Kishi Y; Iwamoto M; Nakamura M; Sando Y; Yagita H; Koreth J; Kim HT; Alyea EP; Armand P; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Maeda Y; Tanimoto M; Ritz J; Matsuoka KI
    Blood; 2017 Apr; 129(15):2186-2197. PubMed ID: 28151427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy.
    Brunner-Weinzierl MC; Rudd CE
    Front Immunol; 2018; 9():2737. PubMed ID: 30542345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.